
Live from IDWeek 2025: Infectious Diseases Hot Takes
Let's Talk ID
00:00
Staph aureus bacteremia practice-changing trials
Paul highlights SNAP and DOTS trials showing cefazolin and dalbavancin change SAB and OPAT management possibilities.
Play episode from 14:10
Transcript


